S Y Na1, S Y Park, H H Cho, J W Choi, M Choi, H S Park, K H Cho. 1. Department of Dermatology, Seoul National University College of Medicine, Seoul, KoreaDepartment of Dermatology, Seoul National University Boramae Hospital, Seoul, Korea.
Abstract
BACKGROUND: Erythema induratum of Bazin (EIB) is regarded to be a hypersensitive reaction to the concomitant tuberculosis. Recently, interferon-γ releasing assay (IGRA) has been focused as a promising tool in the diagnosis of latent tuberculosis. However, there has been no large scale study to investigate the usefulness of IGRA in the diagnosis of EIB. OBJECTIVES: To evaluate the diagnostic performance for the detection of EIB. METHODS: We retrospectively reviewed medical records of all patients with EIB, in the Department of Dermatology, at the Seoul National University Hospital, between April 2009 and September 2011. We analysed clinicopathological features, responses to IGRA and the treatment courses. In addition, we compared positive rate of IGRA in patients with other diseases during the same period. RESULTS: All of the 22 patients demonstrated a positive response to IGRA (100%) and showed a good response to anti-tuberculosis treatment. In contrast, positive rate was 63.64% and 66.67% in patients with psoriasis and other vasculitis respectively. We observed complete resolution of skin lesions in 14 patients. Partial resolution was attained in one patient and the other seven patients are currently on the medication and are showing good responses. CONCLUSION: We verified that IGRA has an excellent diagnostic performance in EIB, through this observational study. It is strongly suggested that if EIB is clinicopathologically suspected, IGRA should be performed.
BACKGROUND:Erythema induratum of Bazin (EIB) is regarded to be a hypersensitive reaction to the concomitant tuberculosis. Recently, interferon-γ releasing assay (IGRA) has been focused as a promising tool in the diagnosis of latent tuberculosis. However, there has been no large scale study to investigate the usefulness of IGRA in the diagnosis of EIB. OBJECTIVES: To evaluate the diagnostic performance for the detection of EIB. METHODS: We retrospectively reviewed medical records of all patients with EIB, in the Department of Dermatology, at the Seoul National University Hospital, between April 2009 and September 2011. We analysed clinicopathological features, responses to IGRA and the treatment courses. In addition, we compared positive rate of IGRA in patients with other diseases during the same period. RESULTS: All of the 22 patients demonstrated a positive response to IGRA (100%) and showed a good response to anti-tuberculosis treatment. In contrast, positive rate was 63.64% and 66.67% in patients with psoriasis and other vasculitis respectively. We observed complete resolution of skin lesions in 14 patients. Partial resolution was attained in one patient and the other seven patients are currently on the medication and are showing good responses. CONCLUSION: We verified that IGRA has an excellent diagnostic performance in EIB, through this observational study. It is strongly suggested that if EIB is clinicopathologically suspected, IGRA should be performed.
Authors: Karen Bjorn-Mortensen; Karin Ladefoged; Jacob Simonsen; Sascha W Michelsen; Hans Christian F Sørensen; Anders Koch; Troels Lillebaek; Aase Bengaard Andersen; Bolette Soborg Journal: Int J Circumpolar Health Date: 2016-10-25 Impact factor: 1.228